CORMEDIX INC's ticker is CRMD and the CUSIP is 21900C308. A total of 63 filers reported holding CORMEDIX INC in Q4 2019. The put-call ratio across all filers is 7.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $185 | -6.6% | 50,000 | 0.0% | 0.14% | -1.4% |
| Q2 2023 | $198 | -4.3% | 50,000 | 0.0% | 0.14% | -6.5% |
| Q1 2023 | $207 | -1.9% | 50,000 | 0.0% | 0.15% | -4.3% |
| Q4 2022 | $211 | -99.9% | 50,000 | 0.0% | 0.16% | +40.0% |
| Q3 2022 | $142,000 | -29.4% | 50,000 | 0.0% | 0.12% | -25.3% |
| Q2 2022 | $201,000 | -26.6% | 50,000 | 0.0% | 0.15% | -19.8% |
| Q1 2022 | $274,000 | +20.2% | 50,000 | 0.0% | 0.19% | +26.3% |
| Q4 2021 | $228,000 | -1.7% | 50,000 | 0.0% | 0.15% | -10.1% |
| Q3 2021 | $232,000 | -32.4% | 50,000 | 0.0% | 0.17% | -32.7% |
| Q2 2021 | $343,000 | -31.4% | 50,000 | 0.0% | 0.25% | -36.1% |
| Q1 2021 | $500,000 | +34.4% | 50,000 | 0.0% | 0.39% | +30.6% |
| Q4 2020 | $372,000 | +23.2% | 50,000 | 0.0% | 0.30% | +13.2% |
| Q3 2020 | $302,000 | -4.1% | 50,000 | 0.0% | 0.27% | -9.5% |
| Q2 2020 | $315,000 | -13.5% | 50,000 | 0.0% | 0.29% | -12.8% |
| Q4 2019 | $364,000 | +14.1% | 50,000 | 0.0% | 0.34% | +10.1% |
| Q3 2019 | $319,000 | – | 50,000 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spinnaker Capital LLC | 175,384 | $649 | 100.00% |
| PLANNING DIRECTIONS INC | 50,000 | $185 | 0.14% |
| Castellan Group | 30,000 | $110,700 | 0.08% |
| Wick Capital Partners, LLC | 35,985 | $133,145 | 0.08% |
| GSG Advisors LLC | 30,000 | $111,000 | 0.05% |
| Elliott Investment Management L.P. | 1,550,523 | $5,736,935 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 74,763 | $276,623 | 0.04% |
| NOMURA HOLDINGS INC | 2,951,532 | $10,920,668 | 0.03% |
| American Financial Advisors, LLC | 30,527 | $112,950 | 0.02% |
| Advisor OS, LLC | 25,000 | $92,500 | 0.01% |